Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes.

Studies have argued that genetic testing will provide limited information for predicting the probability of common diseases, because of the incomplete penetrance of genotypes and the low magnitude of associated risks for the general population. Such studies, however, have usually examined the effect of one gene at time. We argue that disease prediction for common multifactorial diseases is greatly improved by considering multiple predisposing genetic and environmental factors concurrently, provided that the model correctly reflects the underlying disease etiology. We show how likelihood ratios can be used to combine information from several genetic tests to compute the probability of developing a multifactorial disease. To show how concurrent use of multiple genetic tests improves the prediction of a multifactorial disease, we compute likelihood ratios by logistic regression with simulated case-control data for a hypothetical disease influenced by multiple genetic and environmental risk factors. As a practical example, we also apply this approach to venous thrombosis, a multifactorial disease influenced by multiple genetic and nongenetic risk factors. Under reasonable conditions, the concurrent use of multiple genetic tests markedly improves prediction of disease. For example, the concurrent use of a panel of three genetic tests (factor V Leiden, prothrombin variant G20210A, and protein C deficiency) increases the positive predictive value of testing for venous thrombosis at least eightfold. Multiplex genetic testing has the potential to improve the clinical validity of predictive testing for common multifactorial diseases.

[1]  Holtzman Na,et al.  Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. , 1999, Journal of child and family nursing.

[2]  P. McCullagh,et al.  Generalized Linear Models , 1992 .

[3]  L. Welin,et al.  DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN THE GENERAL POPULATION. THE STUDY OF MEN BORN IN 1913 , 1997 .

[4]  A. Albert,et al.  On the use and computation of likelihood ratios in clinical chemistry. , 1982, Clinical chemistry.

[5]  N A Holtzman,et al.  Predictive genetic testing: from basic research to clinical practice. , 1997, Science.

[6]  N. Holtzman,et al.  Will genetics revolutionize medicine? , 2000, The New England journal of medicine.

[7]  Wylie Burke,et al.  The complexities of predictive genetic testing , 2001, BMJ : British Medical Journal.

[8]  P. Ridker,et al.  Age-Specific Incidence Rates of Venous Thromboembolism among Heterozygous Carriers of Factor V Leiden Mutation , 1997, Annals of Internal Medicine.

[9]  U. Seligsohn,et al.  Genetic susceptibility to venous thrombosis. , 2001, The New England journal of medicine.

[10]  F. Collins,et al.  Shattuck lecture--medical and societal consequences of the Human Genome Project. , 1999, The New England journal of medicine.

[11]  Fagan Tj Letter: Nomogram for Bayes theorem. , 1975 .

[12]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[13]  R. White,et al.  Incidence of Idiopathic Deep Venous Thrombosis and Secondary Thromboembolism among Ethnic Groups in California , 1998, Annals of Internal Medicine.

[14]  P. Vineis,et al.  Misconceptions about the use of genetic tests in populations , 2001, The Lancet.

[15]  S Greenland,et al.  Tests for interaction in epidemiologic studies: a review and a study of power. , 1983, Statistics in medicine.

[16]  C. Rotimi,et al.  The new genetics in clinical practice , 1998, BMJ.

[17]  M J Khoury,et al.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.

[18]  L. Pickle,et al.  The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. , 1992, Journal of clinical epidemiology.

[19]  D B Matchar,et al.  Likelihood ratios for continuous test results--making the clinicians' job easier or harder? , 1993, Journal of clinical epidemiology.

[20]  N. Wald,et al.  Antenatal and neonatal screening , 2000 .

[21]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[22]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[23]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[24]  A. Beaudet Making Genomic Medicine a Reality , 1999 .

[25]  B. Lindblad,et al.  A prospective study of the incidence of deep‐vein thrombosis within a defined urban population , 1992, Journal of internal medicine.

[26]  Francis S. Collins,et al.  Genomic medicine--a primer. , 2002, The New England journal of medicine.

[27]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[28]  J. Barber,et al.  "Code of practice and guidance on human genetic testing services supplied direct to the public". Advisory Committee on Genetic Testing. , 1998, Journal of medical genetics.

[29]  E. Southern,et al.  DNA chips: analysing sequence by hybridization to oligonucleotides on a large scale. , 1996, Trends in genetics : TIG.